Genomic – Reflexio

A Genome Every 200 Euros, a Decision Nobody Can Sign

The cost of reading a human genome has fallen so far that the accountant, not the geneticist, is now the bottleneck. Illumina’s NovaSeq X platform, deployed in fourteen European reference labs by early 2025, has pushed whole genome sequencing below 200 euros per sample, and Ultima Genomics is testing sub-100-dollar runs. What was once a…

The Autonomous Genomic Agent Europe Will Not Let Prescribe

magine a piece of software designed to do something clinically simple and legally impossible. It reads a patient’s whole-genome sequence, cross-references their electronic health records, identifies a pathogenic variant with a known targeted therapy, orders a confirmatory laboratory test, updates the treatment plan, and writes a prescription that lands in the pharmacy back-end. No human…

Europe’s Genomic Inflection Meets the Autonomous Agent

The genome has gone from museum exhibit to moving conveyor belt. Sequencers now decode three billion base pairs at a unit cost that would have looked absurd a decade ago, and the next layer of machinery, autonomous AI agents that interpret variants and trigger clinical actions, is already brushing against the walls of European hospitals.…